You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

ASMANEX TWISTHALER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Asmanex Twisthaler patents expire, and what generic alternatives are available?

Asmanex Twisthaler is a drug marketed by Organon Llc and is included in one NDA.

The generic ingredient in ASMANEX TWISTHALER is mometasone furoate. There are thirty drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Asmanex Twisthaler

A generic version of ASMANEX TWISTHALER was approved as mometasone furoate by PADAGIS US on March 18th, 2002.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ASMANEX TWISTHALER?
  • What are the global sales for ASMANEX TWISTHALER?
  • What is Average Wholesale Price for ASMANEX TWISTHALER?
Drug patent expirations by year for ASMANEX TWISTHALER
Drug Prices for ASMANEX TWISTHALER

See drug prices for ASMANEX TWISTHALER

Recent Clinical Trials for ASMANEX TWISTHALER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Merck Sharp & Dohme Corp.Phase 3
Merck Sharp & Dohme Corp.Phase 4

See all ASMANEX TWISTHALER clinical trials

Pharmacology for ASMANEX TWISTHALER

US Patents and Regulatory Information for ASMANEX TWISTHALER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Llc ASMANEX TWISTHALER mometasone furoate POWDER;INHALATION 021067-002 Feb 1, 2008 RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Organon Llc ASMANEX TWISTHALER mometasone furoate POWDER;INHALATION 021067-001 Mar 30, 2005 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ASMANEX TWISTHALER

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Llc ASMANEX TWISTHALER mometasone furoate POWDER;INHALATION 021067-002 Feb 1, 2008 ⤷  Sign Up ⤷  Sign Up
Organon Llc ASMANEX TWISTHALER mometasone furoate POWDER;INHALATION 021067-001 Mar 30, 2005 ⤷  Sign Up ⤷  Sign Up
Organon Llc ASMANEX TWISTHALER mometasone furoate POWDER;INHALATION 021067-001 Mar 30, 2005 ⤷  Sign Up ⤷  Sign Up
Organon Llc ASMANEX TWISTHALER mometasone furoate POWDER;INHALATION 021067-002 Feb 1, 2008 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ASMANEX TWISTHALER

See the table below for patents covering ASMANEX TWISTHALER around the world.

Country Patent Number Title Estimated Expiration
Israel 112459 Use of mometasone furoate in the manufacture of a medicament for treating airway passage and lung diseases ⤷  Sign Up
Japan H11286447 USE OF MOMETASONE FUROATE FOR TREATMENT OF DISEASES OF AIRWAY PASSAGE AND LUNG ⤷  Sign Up
Portugal 1174138 ⤷  Sign Up
Finland 962828 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for ASMANEX TWISTHALER

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0548114 SPC/GB97/064 United Kingdom ⤷  Sign Up PRODUCT NAME: MOMETASONE FUROATE MONOHYDRATE; REGISTERED: FR AMM 343012.6 19970219; UK 00201/0216 19970410
3043773 2190041-0 Sweden ⤷  Sign Up PRODUCT NAME: MOMETASONE OR A SALT THEREOF AND OLOPATADINE OR A SALT THEREOF; NAT. REG. NO/DATE: MT NR 60226 20210519; FIRST REG.: AT APPROVAL NR 140638 20210426
3043773 132021000000191 Italy ⤷  Sign Up PRODUCT NAME: MOMETASONE O UN SUO SALE E OLOPATADINA O UN SUO SALE(RYALTRIS); AUTHORISATION NUMBER(S) AND DATE(S): 048499014, 048499026, 048499038, 20210726;140638, 20210426
0112669 96C0002 Belgium ⤷  Sign Up PRODUCT NAME: MOMETASONE FUROATE; NAT. REGISTRATION NO/DATE: NL 19601 19950919; FIRST REGISTRATION: GR - 10681/89 19900622
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.